Sign in

CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company

ATOSSA THERAPEUTICS, INC.

Sign in to watch
Ticker
ATOS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
264753208
Phone
206.588.0256
Business address
1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
Former names
ATOSSA GENETICS INC
  1. 3 Insider Initial Statement of Ownership
  2. 8-K Event Executive or director change
  3. 8-K Event Delisting notice
  4. 8-K Event Other events
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. 8-K Event Delisting notice
  8. 8-K Event Regulation FD disclosure
  9. 8-K Event Delisting notice
  10. 4 Open-market buy EVP & CFO bought 50,000 shares at $0.97 ($48,500)
  11. 4 Derivatives Options or other derivatives
  12. 8-K Event Executive or director change
  13. 8-K Event Auditor change
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 33 · 643 filings